03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Tarivid IV* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Aventis Deutschland GmbH |
Origin | Germany |
Manufacturer | Sanofi Aventis Deutschland GmbH |
Origin | Germany |
ATC | J01MA01 |
Tarivid IV* :
Tarivid IV* :
Tarivid IV* :
Tarivid IV* :
Tarivid IV* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Tarivid IV* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Achilles tendon rupture | Very rare |
Acute generalised exanthematous pustulosis (AGEP) | Not known |
Acute hepatic failure | Not known |
Acute interstitial nephritis | Not known |
Ageusia (Taste loss) | Not known |
Agitation | Uncommon |
Agranulocytosis | Not known |
ALT increased | Rare |
Anaemia | Very rare |
Anaphylactic reactions | Rare |
Anaphylactic shock | Very rare |
Anaphylactoid reactions | Rare |
Anaphylactoid shock | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Anorexia | Rare |
Anxiety | Rare |
Arthralgia (Pain joint) (Joint ache) | Very rare |
Arthritis | Not known |
AST increased | Rare |
Auditory disorder | Not known |
Back pain | Not known |
Blood alkaline phosphatase increased | Rare |
Blood bilirubin increased | Rare |
Bone marrow depression | Not known |
Bronchospasm | Rare |
Cephalea | Uncommon |
Chest pain | Not known |
Confusional state | Rare |
Constipation | Not known |
Convulsion | Very rare |
Coordination disturbance | Very rare |
Cough | Uncommon |
Depression | Rare |
Dermatitis exfoliative | Not known |
Diarrhoea (Diarrhea) | Uncommon |
Dizziness | Uncommon |
Drug eruption | Very rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Rare |
Dyskinesia | Not known |
Dyspepsia | Not known |
Dyspnoea (dyspnea) | Rare |
Enterocolitis | Rare |
Enterocolitis haemorrhagic | Rare |
Eosinophilia | Very rare |
Epidermal necrosis | Very rare |
Erythema multiforme | Very rare |
Extrapyramidal symptoms | Very rare |
Eye irritation | Uncommon |
Fatigue | Not known |
Fever | Not known |
Flatulence | Not known |
Fungal infection | Uncommon |
Gamma-GT increased | Rare |
Haemolytic anemia | Very rare |
Hallucination | Rare |
Hearing loss | Very rare |
Hepatic lesion | Not known |
Hepatitis | Not known |
Hot flush | Rare |
Hyperglycaemia | Not known |
Hyperhidrosis | Rare |
Hypoglycaemia | Not known |
Hypoglycaemic coma | Not known |
Hypotension | Rare |
Insomnia | Uncommon |
Jaundice cholestatic (Cholestatic icterus) | Very rare |
LDH elevated | Rare |
Leucopenia (Leukopenia) | Very rare |
Ligament rupture | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Muscle rupture | Not known |
Muscle weakness | Not known |
Myalgia | Very rare |
Myasthenia gravis aggravated | Not known |
Myopathy | Not known |
Nasopharyngitis | Uncommon |
Nausea | Uncommon |
Nervousness | Not known |
Nightmares | Rare |
Pain | Not known |
Pain in extremity (Pain in limb) | Not known |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Rare |
Parosmia | Rare |
Pathogen resistance | Uncommon |
Peripheral sensorimotor neuropathy | Very rare |
Peripheral sensory neuropathy | Very rare |
Photosensitivity reaction | Very rare |
Pneumonia | Not known |
Pruritus | Uncommon |
Pseudomembranous colitis | Very rare |
Psychotic disorders | Not known |
QT interval prolonged (QT prolongation) | Not known |
Rash pustular | Rare |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
Rhabdomyolysis | Not known |
Serum creatinine increased | Rare |
Skin necrosis | Very rare |
Skin rash | Uncommon |
Sleep disorder (Sleep disturbance) | Uncommon |
Somnolence | Rare |
Stevens-Johnson syndrome | Not known |
Stomatitis | Not known |
Suicidal ideation | Not known |
Suicide attempt | Not known |
Syncope | Not known |
Tachycardia | Rare |
Tendinitis (Tendonitis) | Rare |
Tendon rupture | Very rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Tinnitus | Very rare |
Torsade de pointes | Not known |
Tremor | Not known |
Urticaria | Rare |
Uveitis | Not known |
Vascular purpura | Very rare |
Vasculitides | Very rare |
Ventricular arrhythmia | Not known |
Vertigo | Uncommon |
Visual disturbance | Rare |
Vomiting | Uncommon |
Tarivid IV* :
NB : Products With Same Indication |
Different Units By MoH Code
Tarivid IV* MoH 2891 :
Form | Solution for infusion |
Packaging | Bottle |
Package Size | 5x100ml |
Strength | 200mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27390 |
Submission date | 01/01/1988 |
Registration Year | 1988 |
Archived Date | 2017 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 5 | |
● Public Price: | 122.15 CHF | ( 12,632,753.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 24,43 CHF | ( 2,482,080.00 LBP ) |
● Exfactory Price: | 92.13 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 100ml | |
● Public Price: | 409.8 SAR | ( 9,687,672.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 81,96 SAR | ( 1,914,840.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1x100ml | |
● Public Price: | 16.16 GBP | ( 1,836,567.84 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 16,16 GBP | ( 1,818,384.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1x100 ml | |
● Public Price: | 12.3 EUR | ( 1,191,574.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 12,3 EUR | ( 1,162,512.00 LBP ) |
● Medica Comments: | SURNOX=Tarivid | |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File